Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vital KSK HoldingsTSE:3151 +1.30%69 ROC (Joel Greenblatt) % is 18.45% as of Mar. 2026, which is 7% above its 10-year median of 17.23. GuruFocus rates TSE:3151 with a GF Score™ of 69/100 and a GF Value™ of 円1,326.12 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, Vital KSK Holdings ranks better than 60.17% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Vital KSK Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 18.45%.
The historical rank and industry rank for Vital KSK Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:
TSE:3151'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 5.7 Med: 17.23 Max: 23.25
Current: 23.25
During the past 13 years, Vital KSK Holdings's highest ROC (Joel Greenblatt) % was 23.25%. The lowest was 5.70%. And the median was 17.23%.
TSE:3151's ROC (Joel Greenblatt) % is ranked better than 60.17% of 118
companies
in the Medical Distribution industry
Industry Median: 16.185
vs TSE:3151: 23.25
Vital KSK Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 24.80% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Vital KSK Holdings ROC (Joel Greenblatt) % Related Terms
Vital KSK Holdings ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Vital KSK Holdings's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3151 vs MCK, CAH, COR: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, Vital KSK Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital KSK Holdings ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Vital KSK Holdings's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 18.45% mean?
Vital KSK Holdings (TSE:3151) has a ROC (Joel Greenblatt) % of 18.45% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Vital KSK Holdings and its competitors. This is near median its historical median of 17.23. Over the past decade, Vital KSK Holdings' ROC (Joel Greenblatt) % has ranged from 5.70 to 23.25. According to the industry distribution chart, Vital KSK Holdings ranks #47 out of 118 companies in the Medical Distribution industry, placing it in the top 39.8%.
Is Vital KSK Holdings' ROC (Joel Greenblatt) % too high?
Vital KSK Holdings' current ROC (Joel Greenblatt) % of 18.45% is near median its 10-year median of 17.23. Over the past 10 years, this metric has ranged from a low of 5.70 to a high of 23.25. The Medical Distribution industry median ROC (Joel Greenblatt) % is 16.19. Vital KSK Holdings' value of 18.45% is 14% above this industry median. Based on the distribution chart, Vital KSK Holdings ranks #47 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Vital KSK Holdings has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' ROC (Joel Greenblatt) % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Vital KSK Holdings ranks #47 out of 118 companies for ROC (Joel Greenblatt) %. This puts Vital KSK Holdings in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 16.19. Vital KSK Holdings' value of 18.45% is 14% above this benchmark. Historically, Vital KSK Holdings' own ROC (Joel Greenblatt) % has ranged from 5.70 to 23.25 over the past decade. While the company's 10-year median is 17.23 vs. the industry median of 16.19, Vital KSK Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 16.19, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital KSK Holdings's current ROC (Joel Greenblatt) % of 18.45% is 14% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Vital KSK Holdings and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 16.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current ROC (Joel Greenblatt) % is 18.45%, which is near median its own 10-year median of 17.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,326.12, compared to a current price of 円1,635.00 — trading 23.3% above its estimated fair value. The current ROC (Joel Greenblatt) % is 18.45%, which is near median its 10-year median of 17.23 and 14% above the Medical Distribution industry median of 16.19. Vital KSK Holdings' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current ROC (Joel Greenblatt) % is 18.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of 円1,635.00 is trading 23.3% above its estimated GF Value™ of 円1,326.12.
GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.
Key valuation signals for TSE:3151:
ROC (Joel Greenblatt) %: 18.45% (near median its 10-year median of 17.23)
GF Value™: 円1,326.12 vs. price of 円1,635.00 (23.3% above fair value)
Industry Position: 14% above the Medical Distribution median (#47 of 118)
No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
69GF Score
Get the complete analysis for TSE:3151
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3151 has been successfully added to your 
